BCDG

James Leary, Professor of Basic Medical Sciences and Biomedical Engineering
Dr. Leary is finding new methods for breast cancer diagnostics and therapeutics using nanomedicine techniques.  Peptide- and antibody-guided nanomedical systems containing drugs or genes for therapy are being developed and tested in animals. The cores of these nanomedical systems are magnetic resonance imaging (MRI) contrast agents, so improved diagnostics should come simultaneously with improved therapeutics. These systems should allow for better targeting of cancer therapies to tumor cells with fewer side effects to normal cells.

For more information on Dr. Leary, visit his department website here.